Men with Stage IV breast cancer who are receptive to systemic therapy benefit from surgery
Men with Stage IV breast cancer and known estrogen (ER) and progesterone receptor (PR) status benefit from surgical intervention and
Read more
Men with Stage IV breast cancer and known estrogen (ER) and progesterone receptor (PR) status benefit from surgical intervention and
Read moreNEW YORK (Reuters Health) – A risk prediction tool for breast cancer in US Black women showed similar accuracy to
Read moreLiz Hurley says two friends found breast cancer after her campaign We use your sign-up to provide content in ways
Read moreNEW YORK (Reuters Health) – Statin use is tied to longer survival in women with triple-negative breast cancer (TNBC), according
Read moreA biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance
Read more(Reuters Health) – Black breast cancer patients with higher adiposity, particularly based on waist-to-hip ratio, are at increased risk of
Read moreNEW YORK (Reuters Health) – Immunomedics’ antibody-drug conjugate sacituzumab govitecan can cut the risk of disease progression or death by
Read moreResearchers at Charité – Universitätsmedizin Berlin and TU Berlin as well as the University of Oslo have developed a new
Read moreAdding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy
Read moreLymph nodes are filters in the lymphatic system that sieve out infectious material as well as toxins that come via
Read more